Loading clinical trials...
Loading clinical trials...
SPECT Imaging of Brain Tumors Using Technetium-99m Labeled 1-Thio-D-Glucose (99mTc-1-thio-D-glucose).
Conditions
Interventions
SPECT or SPECT-CT with 99mTc-1-thio-D-glucose
Locations
1
Russia
TomskNRMC
Tomsk, Russia
Start Date
February 15, 2020
Primary Completion Date
February 15, 2021
Completion Date
February 15, 2021
Last Updated
October 23, 2023
NCT05839379
NCT00026884
NCT05692635
NCT07213804
NCT07169851
NCT07159659
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions